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Abstract
Cognitive-behaviour therapy (CBT) for panic disorder may consist of different combinations of
several therapeutic components such as relaxation, breathing retraining, cognitive restructuring,
interoceptive exposure and/or in vivo exposure. It is therefore important both theoretically and
clinically to examine whether specific components of CBT or their combinations are superior
to others in the treatment of panic disorder. Component network meta-analysis (NMA) is an
extension of standard NMA that can be used to disentangle the treatment effects of different
components included in composite interventions. We searched MEDLINE, EMBASE,
PsycINFO and Cochrane Central, with supplementary searches of reference lists and clinical
trial registries, for all randomized controlled trials comparing different CBT-based psychological
therapies for panic disorder with each other or with control interventions. We applied compo-
nent NMA to disentangle the treatment effects of different components included in these inter-
ventions. After reviewing 2526 references, we included 72 studies with 4064 participants.
Interoceptive exposure and face-to-face setting were associated with better treatment efficacy
and acceptability. Muscle relaxation and virtual-reality exposure were associated with signifi-
cantly lower efficacy. Components such as breathing retraining and in vivo exposure appeared
to improve treatment acceptability while having small effects on efficacy. The comparison of
the most v. the least efficacious combination, both of which may be provided as ‘evidence-
based CBT,’ yielded an odds ratio for the remission of 7.69 (95% credible interval: 1.75 to
33.33). Effective CBT packages for panic disorder would include face-to-face and interoceptive
exposure components, while excluding muscle relaxation and virtual-reality exposure.
Introduction
Panic disorder is an anxiety disorder characterized by the recurrence of unexpected panic
attacks, in which an intense fear accompanied by a series of bodily and/or cognitive symptoms
develops abruptly, without an apparent external cause (American Psychiatric Association,
2013). In the general population, about one-quarter of people suffering from panic disorder
also have agoraphobia (Kessler et al. 2006). Panic disorder is common in the general popula-
tion, with a life-time prevalence of 3.7% without agoraphobia and 1.1% with agoraphobia
(Kessler et al. 2006). In primary care settings, panic syndromes have been reported to have
a prevalence of around 10% (King et al. 2008).
Three types of intervention are recommended for treating individuals with panic disorder
(NICE, 2011). The intervention for which there is evidence for the longest duration of effect is
psychological therapy, followed by pharmacological therapy and self-help. Among various psy-
chological therapies, guidelines recommend the use of cognitive-behaviour psychotherapy
(CBT) (American Psychiatric Association, 1998; Royal Australian & New Zealand College
of Psychiatrists, 2003; NICE, 2011; Katzman et al. 2014). In line with these recommendations,
a recent Cochrane review and network meta-analysis (Pompoli et al. 2016) found CBT to be
the most efficacious treatment among other competing psychological therapies.
CBT for panic disorder is usually administered according to the manuals by Clark &
Salkovskis (Clark & Salkovskis, 1986), Barlow & Craske (Barlow & Craske, 2000) or their adap-
tations. In its classical form, CBT consists of various therapeutic components, mainly repre-
sented by psychoeducation, breathing retraining, muscle relaxation, cognitive restructuring,
interoceptive exposure and in vivo exposure. In clinical practice and in the research literature,
we find therapies which correspond to the general definition of CBT, but which consist of dif-
ferent sets of therapeutic components. It has been observed, however, that some combinations
of these components (i.e. some specific forms of CBT) may lead to better results than their
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isolated administration (Sanchez-Meca et al. 2010). It is therefore
clinically and theoretically important to understand the relative
efficacy of different components of CBT for panic disorder.
Such a component hierarchy will help minimize the complexity
of the treatments being offered and may provide an improvement
in terms of time, money and efforts for both patients and clini-
cians. In addition, streamlining CBT intervention would simplify
therapist training and possibly allow a broader range of clinicians
to be trained, thus improving overall accessibility to CBT.
Component network meta-analysis (NMA) is a newly devel-
oped meta-analysis methodology where various components of
different therapies can be dismantled and compared (Welton
et al. 2009). We have conducted a systematic review of rando-
mized controlled trials (RCTs) comparing various CBT treat-
ments for panic disorder with or without agoraphobia, in terms
of remission, response and dropouts, and applied the component
NMA in order to answer the clinical question ‘Are particular
components of CBT for panic disorder or combinations of such
components more effective than others?’ The objective of the pre-
sent systematic review is to obtain a hierarchy of the components
involved in CBT for panic disorder according to their efficacy and
acceptability and to identify those components associated with
most and least favourable outcomes.
Methods
The analyses have been conducted in adherence to a pre-specified
protocol registered in PROSPERO (CRD42015027601) and the
results are reported following the PRISMA extension statement
for network meta-analysis (Hutton et al. 2015).
Study eligibility criteria
We included all RCTs that compared any form of CBT against
another form of CBT or any other psychotherapeutic control
intervention. We included adult patients of both sexes, with a pri-
mary diagnosis of panic disorder with or without agoraphobia.
We included studies in which diagnoses were made according
to operationalized diagnostic criteria. Table 1 presents the
12 different components of interest and their definition. We
included a psychological therapy or a control intervention as
long as it could be regarded as a combination of these 12 compo-
nents. Table 2 provides a clarification of how the various forms
of CBT were conceptualized according to a component-level
perspective.
Therapies could be of any duration. We included both individ-
ual and group therapies. Pharmacological co-administration was
allowed as long as there were no systematic differences in drug
administration between study arms.
Outcomes
The primary outcome of the study was remission of panic dis-
order with or without agoraphobia in the short term (measured
as close to 3 months as possible, with a maximum of 6 months).
Remission was defined as a dichotomous outcome expressing the
number of patients who reached a satisfactory end-state, as
defined by the original investigators (e.g. achieving a score of 7
or less at end-point on Panic Disorder Severity Scale (PDSS)).
Secondary outcomes included response and dropouts for any rea-
son in the short term. The response was defined as a dichotomous
Table 1. List of included components and their definitions
Component Description
w Waiting component Participants are aware that they will receive an active treatment after a waiting phase. This component was
considered present even when non-specific psychotherapy was provided while the participants were aware
that they could receive the ‘active’ intervention after the waiting period was over
pl Placebo effect Effect of an intervention due to the patients’ belief that they are receiving some form of treatment
ps Psychological support Effect of an intervention due to various non-specific techniques (e.g. encouragement, rationalizing and
reframing, anticipatory guidance, etc.) administered within the context of a therapeutic alliance (Winston et al.
2004). Considered present even in self-help format if personal encouragement was provided to proceed with
the self-help material
pe Psychoeducation It consists in providing patients information about their psychological disease
br Breathing retraining It consists in teaching patients various techniques aimed at correcting those respiratory patterns thought to elicit
or sustain panic attacks
mr Progressive/applied muscle
relaxation
Progressive muscle relaxation is aimed at reducing general tension and achieving a body state that lowers the risk
for stressors to provoke a panic attack (Bernstein & Borkovec, 1973). In the so-called applied relaxation
(Ost, 1987), relaxation training and exposure are combined
cr Cognitive restructuring Psychotherapeutic process of learning to identify and modify irrational or maladaptive thoughts (such as
catastrophic misinterpretation of bodily sensations) using strategies such as Socratic questioning, thought
recording and guided imagery
ine Interoceptive exposure Graded exposure to bodily sensations that accompany panic
ive In vivo exposure Graded exposure to real-life situations perceived as threatening
vre Virtual reality exposure Graded exposure to virtual reality simulations reproducing real-life situations perceived as threatening
3w Third wave components Various techniques aimed at helping patients to develop more adaptive emotional responses to situations, such
as the ability to observe symptomatic processes without overly identifying with them or without reacting to
them in ways that cause further distress (Roemer et al. 2008)
ftf Face-to-face setting Administration of therapeutic components in a face-to-face setting (rather than through self-help means)
Group format was not considered a component because in a previous review and NMA comparing various psychological therapies for the treatment of panic disorder (Pompoli et al, 2016),
we did not detect any association between the relative treatment effects and the difference of therapy delivery (individual v. group) format.
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outcome expressing the number of patients who had a substantial
improvement from baseline, as defined by the original investiga-
tors (e.g. at least 40% reduction in PDSS scores from baseline).
Search strategy
In March 2015, we conducted a comprehensive and systematic
search of all psychological therapies for panic disorder in order
to identify relevant studies for a Cochrane review that has recently
been published (Pompoli et al. 2016). We updated and re-assessed
these search results according to relevant inclusion and exclusion
criteria for this study in November 2015. Online Supplement 1
provides the details of the databases searched, along with supple-
mentary searches and search strategies used.
Data collection
Two review authors independently screened the titles and
abstracts of references identified by the electronic search and
reviewed the full text of any study deemed potentially eligible.
Reviewers resolved disagreements by discussion.
Two review authors used a structured manualized data collec-
tion form to independently extract the data from the included
studies. Any disagreement, including the determination of con-
stituent components of interventions, was resolved either by dis-
cussion or by consultation with a third member of the review
team. We tried to contact the study authors for all relevant miss-
ing data. When this attempt failed, we calculated the number of
remitted and/or responding participants according to a validated
imputation method (Furukawa et al. 2005).
Two review authors independently assessed the risk of bias
(RoB) of the included studies using the Cochrane Risk of Bias
assessment tool (Higgins et al. 2011).
Data synthesis
For the data synthesis, we employed a component NMA model,
similar to the model described in Welton et al. (2009). This
model is an extension of the standard NMA model, where the
effect of each composite intervention is dismantled after modelling
the component-specific effects. We hence differentiated between
the effect of a CBT component and the effect of an intervention
(combination of components). In the primary analyses we assumed
additivity of component effects, i.e. the total effect of each compos-
ite intervention was assumed equal to the sum of effects of the
included components. According to this model, adding a compo-
nent c to a composite intervention X will lead to an increase (or
decrease) of the odds of the event by an amount only dependent
on c, and not on X. We denote the corresponding component-
specific incremental odds ratio by iORc so that iORc =OR(X+c) v. (X).
Combining these component-specific incremental odds ratio
allows the estimation of odds ratios between any two composite
interventions. For example, OR( ftf+ps) v. (w) = iORftf × iORps/iORw
(see Table 1 for the abbreviations of the components).
Consequently, a large iORc suggests that component c has a
large impact on the outcome.
We assessed the assumptions involved in the primary analyses
as follows. First, the NMA requires transitivity of treatment effects
across the network. We evaluated the assumption of transitivity
by comparing the distribution of effect modifiers across studies
Table 2. Conceptualization of various forms of CBT according to a component-level perspective
Interventions or controls Possible decompositions into components
Waiting list (WL) w (±pl ± pe ± ps ± ftf)
No treatment (NT)
Attention/psychological placebo (APP) pl + ftf
Self-help psychoeducation (SH-PE) pl + pe
Face-to-face psychoeducation (PE) pl + pe + ftf
Supportive psychotherapy (SP) pl (±pe) + ps + ftf
Self-help physiological therapy (SH-PT) pl (±pe ± ps) + br/mr
Face-to-face physiological therapy (PT) pl (±pe ± ps) + br/mr + ftf
Self-help cognitive therapy (SH-CT) pl (±pe ± ps ± br ±mr) + cr
Face-to-face cognitive therapy (CT) pl (±pe ± ps ± br ±mr) + cr + ftf
Self-help behaviour therapy (SH-BT) pl (±pe ± ps ± br ±mr) + ine/ive/vre
Face-to-face behaviour therapy (BT) pl (±pe ± ps ± br ±mr) + ine/ive/vre + ftf
Self-help cognitive-behaviour therapy (SH-CBT) pl (±pe ± ps ± br ±mr) + cr + ine/ive/vre
Face-to-face cognitive-behaviour therapy (CBT) pl (±pe ± ps ± br ±mr) + cr + ine/ive/vre + ftf
Self-help third wave CBT (SH-3W) pl (±pe ± ps ± br ±mr ± cr ± ine ± ive ± vre) + 3w
Face-to-face third wave CBT (3W) pl (±pe ± ps ± br ±mr ± cr ± ine ± ive ± vre) + 3w + ftf
w, waiting component; pl, placebo effect; ftf, face-to-face setting; pe, psychoeducation; ps, psychological support; br, breathing
retraining; mr, muscle relaxation; cr, cognitive restructuring; ine, interoceptive exposure; ive, in vivo exposure; vre, virtual reality
exposure; 3w, third wave components.
Note that, abbreviations in uppercase (eg. WL) stand for interventions/controls, whereas abbreviations in lowercase italics stand for
therapeutic components (eg. w). Components in parentheses are elective/optional.
Symbols: ‘+’ means ‘and’; ‘±’ means ‘with or without’; ’/’ means ‘and/or’.
Psychological Medicine 1947
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291717003919
Downloaded from https://www.cambridge.org/core. Universitätsbibliothek Bern, on 14 Dec 2018 at 10:57:21, subject to the Cambridge Core terms of use, available at
grouped by treatment comparisons and components. In addition,
we employed the design-by-treatment interaction test to assess the
consistency of the network statistically (Higgins et al. 2012).
Second, the additivity assumption of the component NMA was
evaluated by comparing the relative intervention effects in appro-
priate subgroups of studies; e.g. studies X + Z v. X should, on aver-
age, estimate the same relative treatment effects as Y + Z v. Y
studies. We also ran sensitivity analyses to examine interaction
terms among important components.
In previous analyses, we found substantial evidence of small
study effects for the comparison of active treatments v. waiting
list with respect to their efficacy (Pompoli et al. 2016).
Consequently, our primary model for response and remission
was a component network meta-regression with the variance of
the study log-odds-ratio as a covariate. No adjustment for small
study effects was done for dropout rate. In order to interpret
the magnitude of the estimated heterogeneity (τ), for each out-
come we compared the estimated heterogeneity with the expected
value, defined in accordance with the empirical distributions for
comparing non-pharmacological interventions for a subjective
outcome (Turner et al. 2012) (median for heterogeneity τ =
0.36; 95% predictive distribution range = 0.07–1.82).
We fitted the model in a Bayesian framework, using
OpenBUGS (Lunn et al. 2009) and uncertainty in the results
was conveyed by the 95% credible intervals (CrI). The model
accounted for correlations induced by multi-arm studies and a
half-normal prior to heterogeneity standard deviation was used.
Online Supplement 2 provides the details of the statistical meth-
ods used.
Results
Results of the search
Our search identified 2526 references. After removal of duplicates
and screening based on title and abstract, 616 references (353
studies) were retrieved for a full inspection. Finally, 72 studies,
representing 4064 participants, were included in quantitative ana-
lyses (online Supplement 3).
Description of studies
Online Supplement 4 summarizes the references and characteris-
tics of the included and excluded studies. Table 3 shows the num-
ber of study arms that included each component. Apart from
third wave components, which were administered only in two
studies (each contributing to only one outcome), all other compo-
nents were well represented in the network. The percentage of
agreement among raters for the identification of components ran-
ged from 99.0 to 99.7%.
The risk of bias of many included studies was judged as
unclear or high in various important domains. Online
Table 3. Number and percentage of study arms including each component and estimates of corresponding incremental odds ratios (iOR) parameter, with 95%
Credible Intervals (CrI), for remission, response and dropouts
Remission Response Dropouts
Component
n (%) of
included arms iOR (95% CrI)
n (%) of
included arms iOR (95% CrI)
n (%) of
included arms iOR (95% CrI)
Third-wave components
(3w)
1 (0.8%) 1.97 (0.34–14.44) 0 (0.0%) 1 (0.75%) 0.55 (0.08–3.63)
Interoceptive exposure
(ine)
54 (40.3%) 1.49 (0.94– 2.36) 48 (38.7%) 1.43 (0.94–2.16) 58 (37.9%) 0.95 (0.53–1.70)
Face-to-face setting (ftf) 82 (61.2%) 1.27 (0.57– 2.66) 78 (62.9%) 1.79 (0.93–3.53) 97 (63.4%) 0.54 (0.17–1.51)
Cognitive restructuring
(cr)
69 (51.2%) 1.11 (0.73– 1.73) 61 (49.2%) 0.87 (0.60–1.27) 74 (48.4%) 1.00 (0.60–1.70)
Placebo effect (pl) 101 (75.4%) 0.97 (0.35–2.48) 94 (75.8%) 1.04 (0.29–3.35) 116 (75.8%) 15.18 (1.67–347.23)
Breathing retraining (br) 45 (33.6%) 0.84 (0.54– 1.26) 40 (32.3%) 1.16 (0.81–1.67) 51 (33.3%) 0.71 (0.45–1.14)
Psychoeducation (pe) 89 (66.4%) 0.84 (0.45– 1.52) 84 (67.7%) 1.17 (0.68–2.03) 100 (65.4%) 0.93 (0.43–2.03)
Psychological support
(ps)
90 (67.2%) 0.79 (0.34– 1.90) 84 (67.7%) 0.86 (0.40–1.84) 105 (68.6%) 1.38 (0.44–4.66)
In vivo exposure (ive) 64 (47.8%) 0.78 (0.50– 1.22) 61 (49.2%) 0.96 (0.66–1.46) 71 (46.4%) 0.86 (0.49–1.48)
Virtual-reality exposure
(vre)
7 (5.22%) 0.71 (0.25– 1.99) 8 (6.5%) 0.41 (0.19–0.84) 6 (3.9%) 1.77 (0.58–5.37)
Muscle relaxation (mr) 30 (22.4%) 0.59 (0.40– 0.90) 29 (23.4%) 0.64 (0.46–0.88) 35 (22.9%) 1.07 (0.64–1.77)
Waiting component (w) 34 (25.4%) 0.38 (0.12– 1.23) 30 (24.9%) 0.80 (0.21– 2.86) 38 (24.8%) 5.26 (0.59–121.51)
τ 0.40 (0.05– 0.73) 0.23 (0.02–0.55) 0.53 (0.11–0.91)
Coefficient of the variance
in the meta-regression
−1.96 (−2.72 to −1.30) −1.66 (−2.26 to −1.08) −
Larger values of the parameters indicate respectively, larger remission, response and dropout rates. Components are ordered according to iORs for remission, from the most to the least
beneficial.
The lower part of the table reports the median heterogeneity standard deviation (τ) for the three outcomes and the regression coefficient for the two outcomes for which analyses were
adjusted for small study effects.
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Supplement 5 provides the RoB assessment for each domain and
for each study. The percentage of agreement among raters for the
assessment of RoB ranged from 75 to 96%.
Assessments of transitivity, inconsistency and additivity
assumption
We compiled a table of important trial and patient characteristics
(therapy duration, percentages of agoraphobic, depressed and
drug-treated patients) across treatment comparisons and compo-
nents. Its visual inspection showed that those effect modifiers
were likely to be similarly distributed across the networks of treat-
ments and components, although there was missing information
from several studies (online Supplement 2). Overall there was little
concern about the plausibility of the transitivity assumption.
After exploring data for inconsistencies, first at the treatment
level and then at the component level, we found no strong evi-
dence of inconsistency for any of the explored outcomes but the
power of this analysis is expected to be low (online Supplement 6).
We did not find any strong evidence against the additivity
assumption (online Supplement 6). Sensitivity analyses examining
several clinically relevant interaction terms in the model ( ftf with
ine, ftf with cr, pe with ine, cr with ive, br with ine, br with ive) did
not alter the results: none of these interactions was statistically sig-
nificant (online Supplement 7).
Primary outcome: remission of panic disorder
Data regarding remission were available from 60 studies, with a
total of 134 study arms (3556 patients). Figure 1 shows the net-
work at the treatment level and at the component level.
Including the variance of the treatment effect in the
meta-regression model reduced the median heterogeneity stand-
ard deviation from τ = 0.85 (0.56–1.22) to τ = 0.40 (0.05–0.73)
and the regression coefficient was estimated to be −1.96 (−2.72
to −1.30) providing strong evidence for the presence of small
study effects. Heterogeneity was found to be close to the expected
values (Turner et al. 2012). The results from the network
meta-regression are presented in Table 3.
The inclusion of third-wave components, interoceptive expos-
ure, face-to-face setting and cognitive restructuring in a composite
intervention apparently led to higher odds of remission but
uncertainty was large, as seen from the very wide CIs for the cor-
responding iOR (Table 3). Conversely, placebo effect, breathing
retraining, psychoeducation, psychological support, in-vivo expos-
ure and virtual reality exposure were found to decrease the odds
of remission, but again with large uncertainty in the estimates.
However, including muscle relaxation in a complex treatment
was shown to significantly reduce the efficacy in terms of short-
term remission. Results were favourable for third-wave compo-
nents, but with very large uncertainty. As expected, the waiting
component (which is mainly administered without other compo-
nents as a supposedly inert control condition) showed the smal-
lest mean iOR.
Based on the findings of Table 3 (and excluding third wave
components, which was only informed by a single study, and for
which the estimate was very imprecise) we can identify the CBT
associated with the largest remission rates as consisting of ( ftf
+ pl + pe + ps + cr + ine) and the least effective CBT as ( pl + pe +
ps + br +mr + ive + vre); the components of pl, pe and ps are
included here as would be expected in typical CBT programs
but in the calculation of relative efficacy their effects are cancelled
out and the best treatment would provide an average relative
increase in the odds of remission by almost 700% (OR 7.69 CrI
1.75 to 33.33).
Response to the interventions
A total of 55 studies (124 study arms including 3275 patients)
provided evidence on the response. There was evidence of small
study effects in the comparisons of active interventions v. waiting
list. Heterogeneity was found to be within the range of expected
values (Turner et al. 2012). Table 3 gives the values of the iOR
values for response estimated from the component network
meta-regression. Taken together, results about response were in
general agreement with those for remission. Results were more
precise for muscle relaxation and virtual reality exposure, which
appeared to reduce the odds of response.
Dropout rate from the study
Data regarding dropouts was available from 68 studies, with a
total of 153 study arms (3705 patients). Table 3 gives the estimates
of the iOR parameters for dropouts, where values smaller than 1
are associated with higher treatment acceptability. Heterogeneity
was again found to be within the range of expected values
(Turner et al. 2012).
The low estimate for iORftf suggests that dropouts were gener-
ally less frequent in face-to-face therapies than in self-help therap-
ies. Components such as breathing retraining and in vivo exposure
seemed to marginally improve treatment acceptability; the inclu-
sion of psychoeducation, interoceptive exposure, cognitive restruc-
turing and muscle relaxation showed negligible influence on
dropouts. Finally, psychological support and virtual reality expos-
ure were associated with lower acceptability, although the corre-
sponding estimate came with a lot of uncertainty. The placebo
effect was associated with the highest and the waiting component
with the second highest odds of dropout. Because all active inter-
ventions are administered together with the placebo effect, the esti-
mate for this component can be seen as a sort of an average
acceptability of the active treatments. Therefore, our results sug-
gest that the risk of dropout was on average higher in active treat-
ments as a whole than in waiting list (people placed on the
waiting list were more likely to return for the assessment at end
of a trial than people in active treatments). Results were again
favourable but very imprecise for third-wave components.
Discussion
The results of this component NMA seem to support our original
hypothesis that, among the wide range of therapeutic components
that fall within CBT, there are important differences in terms of
efficacy and acceptability. As a consequence, the selection of dif-
ferent combinations of components can greatly influence the out-
come of CBT for panic disorder, explaining at least part of the
heterogeneity observed in previous studies examining this psycho-
logical therapy (Sanchez-Meca et al. 2010; Pompoli et al. 2016).
Based on the analyses for remission after selecting the specific
combination of components in order to have the ‘most efficacious
CBT’ and the ‘least efficacious CBT’, we would include cognitive
restructuring (cr) and interoceptive exposure (ine) in the former,
and breathing retraining (br), muscle relaxation (mr), in vivo
exposure (ive) and virtual reality exposure (vre) in the latter. In
the context of typical CBT, characterized by simultaneous pres-
ence of pl, pe and ps, the comparison of such two CBT versions,
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that is ( ftf + pl + pe + ps + cr + ine) v. ( pl + pe + ps + br +mr + ive
+ vre), would yield an OR of 7.69 (CrI 1.75 to 33.33) in favour
of the ‘most efficacious’ CBT. On the other hand, if we compare
the above defined ‘most efficacious CBT’ and what could be a
commonly delivered CBT, comprising for example ( ftf + pl + pe
+ ps + cr + br + ive), we would still have an OR of 2.33 (CrI 1.01
to 5.26). These contrasts are not only statistically significant but
also have strong clinical implications.
In our previous review (Pompoli et al. 2016) we found that, in
terms of short-term remission, CBT appeared to be significantly
Fig. 1. The network structure for short-term remis-
sion at the composite-interventions level (top) and
at the component level (bottom).
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superior to behaviour therapy, with an OR of 1.79 (CrI 1.02 to
3.13), which suggested that the co-administration of cognitive
and behavioural therapeutic components was superior to the
administration of behavioural components alone. Another review
(Sanchez-Meca et al. 2010) had previously concluded that the
combination of exposure, relaxation/breathing techniques and
cognitive therapy may represent the most effective treatment for
panic disorder, with smaller effect sizes for any of these compo-
nents if administered alone.
The present study, however, goes one step further to suggest
which particular components, within the broad class of cognitive
or behavioural approaches to treat panic disorder, are likely to be
more beneficial. First, among behavioural components, interocep-
tive exposure (ine) tends to be associated with a better outcome
than in vivo exposure (ive). Similar findings were reported in pre-
vious studies, which showed the positive effects of adding ine to
ive alone (Ito et al. 1996; Craske et al. 1997), while showing less
benefits in adding ive to ine alone (de Ruiter et al. 1989; Craske
et al. 2003).
It must be noted that, compared with interoceptive exposure
(ine), the inclusion of cognitive restructuring (cr) was shown to
influence positive outcomes to a lesser degree. The administration
of other components such as breathing retraining (br), psychoedu-
cation ( pe) and placebo effect ( pl) was also shown to have a small
influence on treatment outcome in terms of both response and
remission. Interestingly, breathing retraining (br) is among those
components which showed a low impact on positive outcomes,
although it appeared to improve treatment acceptability. These
findings are coherent with previous studies questioning the utility
of breathing retraining (br) in addition to other CBT components
(Schmidt et al. 2000) or comparing breathing retraining (br) to
interoceptive exposure (ine) (Craske et al. 1997).
On the other hand, the inclusion of muscle relaxation (mr) was
shown to be related to a significantly worse outcome both in terms
of remission and response, although this component did not
appear to influence treatment acceptability. This finding is coherent
with a previous review which found that CBT was superior to relax-
ation therapy in all panic-related domains, although having no
differences in terms of drop-out rates (Siev & Chambless, 2007).
Although two previous reviews, exploring self-help v.
face-to-face CBT for various anxiety disorders (Cuijpers et al.
2010; Lewis et al. 2012), did not detect important differences
between the two delivery forms when analyses were restricted to
studies focusing on panic disorder, a more recent Cochrane
review (Olthuis et al. 2015) found evidence in favor of face-to-face
CBT, compared with therapist-guided internet CBT, in terms of
anxiety reduction (three studies: SMD 0.29; 95% CI 0.03–0.54).
Our study also suggests that the better format for the administra-
tion of CBT is the face-to-face setting, which leads to a better out-
come both in terms of response and remission. Furthermore, it
also seems to improve patients’ adherence to the treatment, redu-
cing the number of dropouts. Finally, we found only two studies
exploring third-wave components (Karekla, 2004; Berger et al.
2014), only one of which contributed data. Further studies explor-
ing third-wave CBTs for panic disorder are warranted.
We were unable to detect any interaction among the compo-
nents when we added interaction terms as would be expected
from clinical or theoretical notions (e.g. Would the efficacy of
interoceptive exposure or cognitive restructuring be stronger in
face-to-face rather than otherwise? Would psychoeducation facili-
tate interoceptive exposure? Would cognitive restructuring
enhance the efficacy of in vivo exposure? Could breathing
retraining be used as a counterproductive safety behaviour during
interoceptive or in vivo exposures?). However, it should be noted
that our data were sparse and generally had low power to detect
interactions. Thus, our findings should not be interpreted as rul-
ing out the possibility of synergistic/antagonistic effects between
some CBT components. Future large studies may still be able to
detect clinically important interactions.
This review has some weaknesses. First of all, the high number
of included studies together with the complexity of statistical ana-
lyses took us a long time to complete the review since the search
date. Second, despite our efforts, we have probably been unable to
include all unpublished studies, as suggested by the evidence of
SSE affecting both remission and response. Third, it must be
noted that some results came with a high degree of uncertainty
as regards each individual component, possibly due to the limited
number of relevant studies and heterogeneity among them. In the
previous NMA comparing various psychological therapies for the
treatment of panic disorder (Pompoli et al. 2016), however, we
did not detect any association between the relative treatment
effects and study-level characteristics such as year of publication,
percentage of drug-treated patients, percentage of patients with
comorbid depression, percentage of agoraphobic patients and
therapy delivery setting (individual v. group therapy). Fourth,
included studies were often assessed as being at unclear risk of
bias for random sequence generation, allocation concealment or
selective outcome reporting and a high percentage of studies
were assessed as being at high risk of outcome assessment bias,
attrition bias and researcher allegiance bias. In addition, different
studies used variable definitions of remission or response. While
we expect that such differences would more strongly affect abso-
lute measures of efficacy (What percentage of patients respond?)
and less strongly relative measures of efficacy (How much more
likely are patients to respond on treatment than on control?)
(Furukawa et al. 2002), this variability may be one reason that
has contributed to uncertainty of estimates in the present ana-
lyses. Fifth, the definitions and identifications of components in
the broad range of CBT are unavoidably arbitrary to some degree.
However, we tried to be as transparent as possible by providing
explicit definitions and we were able to achieve satisfactory agree-
ment in the judgments between two independent reviewers.
Finally, we did not include any long-term outcome, aware of
the limited availability of relevant data (Pompoli et al. 2016).
This study has some important strengths, however. To our
knowledge, this study is among the first attempts to implement a
component-level network meta-analyses within the context of a
comprehensive and methodologically rigorous systematic review,
and represents a pioneering approach to disentangle the individual
contributions of every single component pertaining to a complex
intervention such as CBT for panic disorder. The high number
of included studies, the lack of evidence against the assumptions
of transitivity or additivity in the networks and the coherence
between results for remission and response, suggest the robustness
of our findings.
The identification of important differences between compo-
nents of CBT has strong implications for clinical practice by con-
tributing to a much more precise identification of those
therapeutic components that should be included (or excluded)
when offering CBT to patients affected by the panic disorder.
More effective CBT packages for panic disorder would include
face-to-face and interoceptive exposure components, while the
inclusion of muscle relaxation or virtual reality exposure would
decrease the overall efficacy of such CBT packages. The inclusion
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of other components, such as psychoeducation, cognitive restruc-
turing, breathing retraining and exposure in vivo, seems to have
a lower impact on treatment outcome, and could be appropriate
depending on theoretical and pragmatic considerations.
Although some components are associated with worse treat-
ment outcome, one must keep in mind that, both in terms of
remission and response, all components appear to be beneficial
when compared with inert waiting list (the only exception is vir-
tual reality exposure for response). This means that such compo-
nents cannot be considered ‘detrimental’; rather, it can be
hypothesized that, given that a treatment takes a limited amount
of time, administering less effective components may lead to a
worse/limited administration of the more effective ones, finally
leading to a less positive clinical result.
The results from this study also have important implications
for future research in complex interventions. Researchers should
evaluate the possibility to exploit the used methodology in
order to reach a better understanding of advantages and disad-
vantages of various components included in complex interven-
tions, such as psychotherapies and many other public health
interventions.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291717003919.
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